Dublin, Jan. 08, 2021 (GLOBE NEWSWIRE) -- The "Alcoholic Hepatitis - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
This 'Alcoholic Hepatitis - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical, and forecasted Alcoholic Hepatitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
This section encompassing Alcoholic Hepatitis epidemiology provides insights about historical and current patient pool and forecasted trends for every seven major countries. The Alcoholic Hepatitis epidemiology data are studied through all possible divisions to better understand the disease scenario in 7MM. This segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports, and views of key opinion leaders.
Detailed Epidemiology Segmentation
The Alcoholic Hepatitis epidemiology covered in the report provides historical as well as forecasted Alcoholic Hepatitis epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
11-year Forecast of Alcoholic Hepatitis Epidemiology
Total Prevalent cases of Alcoholic Hepatitis
Diagnosed Cases of Alcoholic Hepatitis
Severity-specific Cases of Alcoholic Hepatitis
Gender-specific Cases of Alcoholic Hepatitis
Disease Risk and Burden
Risk of disease by the segmentation
Factors driving growth in a specific patient population
Key Topics Covered:
1. Key Insights
2. Executive Summary of Alcoholic Hepatitis
3. SWOT Analysis for Alcoholic Hepatitis
4. Alcoholic Hepatitis: Disease Overview
4.2. Alcoholic Liver Disease
4.4. Signs and Symptoms
4.5. Clinical Presentation
4.9. Risk Factors
4.10.1. Differential Diagnosis
5. Epidemiology and Patient Population
5.1. Key Findings
6. 7MM Epidemiology
6.1. Assumptions and rationale
6.2. Diagnosed Moderate to Severe Cases of Alcoholic Hepatitis (AH) in 7MM
6.3. United States
6.3.1. Total Prevalent cases of Alcoholic Hepatitis (AH) in the United States
6.3.2. Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in the United States
6.3.3. Gender-specific cases of Alcoholic Hepatitis (AH) in the United States
6.3.4. Severity-specific cases of Alcoholic Hepatitis (AH) in the United States
6.8. United Kingdom
7. Treatment of Alcoholic Hepatitis
7.1. Treatment Guidelines
8. Unmet Needs
9. Organizations contributing toward AH
10. Case studies
10.1. Alcoholic hepatitis - the case for intensive management
10.2. Case of severe alcoholic hepatitis treated with granulocytapheresis
10.3. Severe Alcoholic Hepatitis: Atypical Presentation with Markedly Elevated Alkaline Phosphatase
10.4. Alcoholic Hepatitis with an Unexpected Histology: A Case Report
11. KOL Views
For more information about this report visit https://www.researchandmarkets.com/r/uzkrvd
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900